seni menulis resep 2
TRANSCRIPT
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 1/16
TATA CARA PENULISAN RESEP
Resep harus BAIK dan RASIONAL
BAIK ? !!! Lengkap (sesuai UU)
dan
eas ("uisan "er#a$a)
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 2/16
BA%ASA &ALA' RESEP
&igunakan
BA%ASA NEERI SEN&IRI a"au
BA%ASA LATIN
(Khususn*a daa+ SINATURA ke$uai CITO,
ITER)
KEUNTUNAN B%S LATIN
STATIS - 'ATI
B%S &UNIA U- KESE%ATAN
NA'A OBAT &L' B%S LATIN T&K &ITA.SIR LAIN
'ERA%ASIAKAN SESUATU P& PEN&ERITA
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 3/16
RASIONAL?!!!
TEPAT OBAT
TEPAT &OSISTEPAT BSO
TEPAT /AKTU
TEPAT CARATEPAT PEN&ERITA
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 4/16
/AKTU PE'BERIAN
"epa"
Tuuan
E0ek 1p"i+a
E0ek sa+ping +ini+aTdk +engganggu ke#iasaan
penderi"a
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 5/16
PERLU &IINAT La+#ung k1s1ng (a2$2) 3 a#s1rpsi $epa"
La+#ung #erisi (p2$2) 3 u+u+n*a a#s2
diha+#a"
Per Rek"a 3 se#aikn*a sesudah de0ikasi
O#a" $a$ing 3 se#eu+ +akan
O#a" *g +e+#ua" +ua 3 sesudah +akan
Laksansia Kera $epa" 3 pagi hari
Kera a+#a" 3 s1re hari
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 6/16
CONTO% /AKTU PE'BERIAN
P2C2 O#a" *g +erangsang asa+ a+#ung
Prepara" #esi Prepara" saisia" A$e"1sa
O#a" *g +en*e#a#kan rasa +ua &ia#e"ika 1ra
A2C2 Se#aikn*a u- se+ua 1#a" U- 4$1n"ras +idde5
An"i spas+1dik
&2C2 U- 1#a" *g +e+pengaruhi pen$ernaan +akanan +is
Pepsin (Prep2 En6i+) 7i"a+in
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 7/16
CARA PE'AKAIAN
"epa"
Tuuan
E0ek 1#a"-hs peng1#a"an
"epa" &i#eri "ahu d1k"er isan
Ter"uis d+ R- e"ike"
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 8/16
'ACA'8'ACA' CARA
Per 1ra
Su#ingua
Peren"era Rek"a
T1pika
Inhaasi
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 9/16
&OSIS OBAT
"epa"
3 d1sis pe+akaian
'a$a+8+a$a+ d1sis
&1sis a6i+
&1sis "erapi &1sis +aksi+u+
&1sis rangkap
&1sis anak
&1sis geria"ri
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 10/16
PROSE&UR PENENTUAN &OSIS TERAPI
OBAT
&L sesuai u+ur-BB
penderi"a
'en$ari a"au +eng
%i"ung &' sesuai
U+ur-BB penderi"a
92 Un"uk pe"unuk
- ped1+an
:2 Bahan per"i+8
#angan
Ten"ukan
Sesuai
Bera"-
Ringan
pen*aki"
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 11/16
RU'US &OSIS
U- anak
Berdasarkan u+ur ;OUN (< = T%)
&1sis 3 n-(n > 9:) d1sis d@s
&iing ( = "h)
&1sis 3 n-: d1sis d@s
.RIE& (< 9 "h)
&1sis 3 +-9 d1sis d@s
CO/LIN
&1sis 3 (n>9)-:D d1sis d@s
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 12/16
BER&ASARKAN BERAT BA&AN
CLARK &1sis 3 /- d1sis d@s
BASE& ON BO&; SUR.ACE AREA I0 adu" d1se is giFen, Appr12 d1se 01r
$hid 3
BSA 10 $hid (in +:) - 92G +: ? adu"
d1se
I0 "he d1se per +: is giFen, Appr12 d1se 01r
$hid 3
BSA 10 $hid (in +: ) &1se per +:
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 13/16
The pres$rip"i1n is Hui"e $1n0using, hard* "1 guess @ha"
drugs are $1+p1unded in "he pres$rip"i1n2
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 14/16
The prescription using un-properly Latin abbreviation
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 15/16
The maximal dose of INH is 10 mg/g !"# therefore# the dosage of
INH mentioned in the prescription above has elevated the
max$dose$ In such prescription should be follo%ed by &exclamation
sign' and &prescriber's initial sign'
7/23/2019 Seni Menulis Resep 2
http://slidepdf.com/reader/full/seni-menulis-resep-2 16/16
(moxan consists of amoxicillin %ith the t1/) * )-+ hours# %hile
cotrimoxa,ale .ulpha has the t1/) * 10-1) hours$ The prescriber
has given the compounded drugs at the same freuency# therefore#
the prescription is not rational since there %ill be a therapeutic
incompatibility problem$